Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Are goblet cell carcinoids a group of heterogeneous tumors

J. Macak, K. Nemejcova, J. Dvorackova

. 2017 ; 161 (3) : 281-285. [pub] 20170612

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025560

BACKGROUND: Goblet cell carcinoids belong to neuroendocrine tumors, according to the WHO classification. The tumors are diagnosed based on a typical histological pattern and using neuroendocrine markers. However, some tumors do not react with these markers and yet expression of proliferative markers is high. Do these tumors belong to G1 and G2 neuroendocrine tumors? METHODS: The sample comprised nine cases of tumors of the appendix identified by immunohistological methods as goblet cell carcinoids or adenocarcinoma ex goblet cell carcinoid. RESULTS: In six cases, hematoxylin and eosin staining revealed tumors completely or 90% made of characteristic large tumor cells observed in typical goblet cell carcinoids. The remaining three cases were identified as adenocarcinomas arising ex goblet cell carcinoids. Immunohistological examination revealed that in four cases of typical goblet cell carcinoids, expression of neuroendocrine markers was low or completely negative. Yet in two cases, the Ki-67 proliferative index exceeded the 20% cut-off for inclusion in the G1 and G2 category. CONCLUSIONS: Goblet cell carcinoids are a heterogeneous group of tumors that may express neuroendocrine markers in a small number of tumor cells or are negative to these markers. However, high expression of the proliferative marker Ki-67 exceeds the criteria for G1 and G2 neuroendocrine tumors. It is our opinion that these tumors may be classified as a specific type of carcinoma.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025560
003      
CZ-PrNML
005      
20180810085207.0
007      
ta
008      
180711s2017 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2017.027 $2 doi
035    __
$a (PubMed)28659644
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Mačák, Jirka, $u Department of Pathology, University of Ostrava and University Hospital Ostrava, Czech Republic; CGB Laboratory Inc., Ostrava, Czech Republic $d 1940- $7 xx0006068
245    10
$a Are goblet cell carcinoids a group of heterogeneous tumors / $c J. Macak, K. Nemejcova, J. Dvorackova
520    9_
$a BACKGROUND: Goblet cell carcinoids belong to neuroendocrine tumors, according to the WHO classification. The tumors are diagnosed based on a typical histological pattern and using neuroendocrine markers. However, some tumors do not react with these markers and yet expression of proliferative markers is high. Do these tumors belong to G1 and G2 neuroendocrine tumors? METHODS: The sample comprised nine cases of tumors of the appendix identified by immunohistological methods as goblet cell carcinoids or adenocarcinoma ex goblet cell carcinoid. RESULTS: In six cases, hematoxylin and eosin staining revealed tumors completely or 90% made of characteristic large tumor cells observed in typical goblet cell carcinoids. The remaining three cases were identified as adenocarcinomas arising ex goblet cell carcinoids. Immunohistological examination revealed that in four cases of typical goblet cell carcinoids, expression of neuroendocrine markers was low or completely negative. Yet in two cases, the Ki-67 proliferative index exceeded the 20% cut-off for inclusion in the G1 and G2 category. CONCLUSIONS: Goblet cell carcinoids are a heterogeneous group of tumors that may express neuroendocrine markers in a small number of tumor cells or are negative to these markers. However, high expression of the proliferative marker Ki-67 exceeds the criteria for G1 and G2 neuroendocrine tumors. It is our opinion that these tumors may be classified as a specific type of carcinoma.
650    _2
$a adenokarcinom $x klasifikace $x patologie $7 D000230
650    _2
$a senioři $7 D000368
650    _2
$a apendektomie $7 D001062
650    _2
$a nádory apendixu $x klasifikace $x patologie $7 D001063
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a karcinoid $x klasifikace $x patologie $7 D002276
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a antigen Ki-67 $x fyziologie $7 D019394
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neuroendokrinní nádory $x klasifikace $x patologie $7 D018358
650    _2
$a Světová zdravotnická organizace $7 D014944
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nemejcova, Kristina $u Department of Pathology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Dvořáčková, Jana, $u Department of Pathology, University of Ostrava and University Hospital Ostrava, Czech Republic; CGB Laboratory Inc., Ostrava, Czech Republic $d 1956- $7 xx0077620
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 161, č. 3 (2017), s. 281-285
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28659644 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20180711 $b ABA008
991    __
$a 20180723101139 $b ABA008
999    __
$a ok $b bmc $g 1324894 $s 1022482
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 161 $c 3 $d 281-285 $e 20170612 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20180711

Najít záznam

Citační ukazatele

Možnosti archivace